India  

Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 cror

Mid-Day Wednesday, 2 June 2021
Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 crorThe Department of Biotechnology has given permission to HBPCL for producing Covaxin under Mission Covid Suraksha. Covaxin has been developed by Bharat Biotech in collaboration with ICMR.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 crore doses a year


newKerala.com